4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-014775
President and CEO sold 9,562 shares at an average $17.22 ($164,658)
- President and CEO acquired 9,562 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2017-04-03 | Option exercise | +4,781 | $0.95 | $4,518 | 6,760 | D: show line 1 in the form |
| McCarthy Sean A. President and CEO | 2017-04-03 | Sale | −4,781 | $16.94 | $80,990 | 1,979 | D: show line 2 in the form |
| McCarthy Sean A. President and CEO | 2017-04-04 | Option exercise | +4,781 | $0.95 | $4,518 | 6,760 | D: show line 3 in the form |
| McCarthy Sean A. President and CEO | 2017-04-04 | Sale | −4,781 | $17.50 | $83,668 | 1,979 | D: show line 4 in the form |
| Open-market sales · 9,562 sh · avg $17.22 · $164,658 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2017-04-03 | Option exercise · Stock Option (right to buy) | −4,781 | 77,634 | D: show line 5 in the form | |||||
| McCarthy Sean A. President and CEO | 2017-04-04 | Option exercise · Stock Option (right to buy) | −4,781 | 72,853 | D: show line 6 in the form |
Loading xslF345X03/doc1.xml…